Literature DB >> 21841493

Early glycemic control in critically ill patients with burn injury.

Claire V Murphy1, Rebecca Coffey, Charles H Cook, Anthony T Gerlach, Sidney F Miller.   

Abstract

Glucose management in patients with burn injury is often difficult because of their hypermetabolic state with associated hyperglycemia, hyperinsulinemia, and insulin resistance. Recent studies suggest that time to glycemic control is associated with improved outcomes. The authors sought to determine the influence of early glycemic control on the outcomes of critically ill patients with burn injury. A retrospective analysis was performed at the Ohio State University Medical Center. Patients hospitalized with burn injury were enrolled if they were admitted to the intensive care unit between March 1, 2006, and February 28, 2009. Early glycemic control was defined as the achievement of a mean daily blood glucose of ≤150 mg/dl for at least two consecutive days by postburn day 3. Forty-six patients made up the study cohort with 26 achieving early glycemic control and 20 who did not. The two groups were similar at baseline with regard to age, pre-existing diabetes, APACHE II score and burn size and depth. There were no differences in number of surgical interventions, infectious complications, or length of stay between patients who achieved or failed early glycemic control. Failure of early glycemic control was, however, associated with significantly higher mortality both by univariate (35.0 vs 7.7%, P = .03) and multivariate analyses (hazard ratio 6.754 [1.16-39.24], P = .03) adjusting for age, TBSA, and inhalation injury. Failure to achieve early glycemic control in patients with burn injury is associated with an increased risk of mortality. However, further prospective controlled trials are needed to establish causality of this association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841493     DOI: 10.1097/BCR.0b013e31822dc3da

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  11 in total

Review 1.  Diabetes mellitus and burns. Part II-outcomes from burn injuries and future directions.

Authors:  Ioannis Goutos; Rebecca Spenser Nicholas; Atisha A Pandya; Sudip J Ghosh
Journal:  Int J Burns Trauma       Date:  2015-03-20

2.  Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.

Authors:  Julia L M Dunn; Laurel B Kartchner; Karli Gast; Marci Sessions; Rebecca A Hunter; Lance Thurlow; Anthony Richardson; Mark Schoenfisch; Bruce A Cairns; Robert Maile
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

3.  Outcomes and complications of diabetic burn injuries: a single center experience.

Authors:  Salah Aldekhayel; Abdullah M Khubrani; Khalid S Alshaalan; Mohammed Barajaa; Obaid Al-Meshal
Journal:  Int J Burns Trauma       Date:  2021-06-15

Review 4.  Burns: an update on current pharmacotherapy.

Authors:  Yesenia Rojas; Celeste C Finnerty; Ravi S Radhakrishnan; David N Herndon
Journal:  Expert Opin Pharmacother       Date:  2012-11-02       Impact factor: 3.889

5.  Incidence of Hypoglycemia in Burn Patients: A Focus for Process Improvement.

Authors:  David M Hill; Sean Lloyd; William L Hickerson
Journal:  Hosp Pharm       Date:  2017-12-07

Review 6.  Blood glucose measurement in the intensive care unit: what is the best method?

Authors:  Huong T Le; Neil S Harris; Abby J Estilong; Arvid Olson; Mark J Rice
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

7.  Response to Burns in the Elderly: What is Pathophysiology and What is Physiology?

Authors:  E Middelkoop; A F P M Vloemans
Journal:  EBioMedicine       Date:  2015-09-07       Impact factor: 8.143

8.  Validity of bedside blood glucose measurement in critically ill patients with intensive insulin therapy.

Authors:  Ata Mahmoodpoor; Hadi Hamishehkar; Kamran Shadvar; Sarvin Sanaie; Afshin Iranpour; Vahid Fattahi
Journal:  Indian J Crit Care Med       Date:  2016-11

9.  The effect of diabetes on burn patients: a retrospective cohort study.

Authors:  Reinhard Dolp; Sarah Rehou; Ruxandra Pinto; Rachel Trister; Marc G Jeschke
Journal:  Crit Care       Date:  2019-01-28       Impact factor: 9.097

Review 10.  Stress hyperglycemia, insulin treatment, and innate immune cells.

Authors:  Fangming Xiu; Mile Stanojcic; Li Diao; Marc G Jeschke
Journal:  Int J Endocrinol       Date:  2014-05-08       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.